Found: 10
Select item for more details and to access through your institution.
Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy.
- Published in:
- Acta Neuropathologica Communications, 2020, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40478-020-01050-0
- By:
- Publication type:
- Article
P2‐294: RETROSPECTIVE REVIEW OF CLINICAL FEATURES OF ABCA7 LOSS‐OF‐FUNCTION MUTATION CARRIERS IN LATE‐ONSET ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P699, doi. 10.1016/j.jalz.2019.06.2701
- By:
- Publication type:
- Article
P1‐160: ABI3 AND PLCG2 AS RISK FACTORS FOR ALZHEIMER'S DISEASE IN CAUCASIANS AND AFRICAN AMERICANS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P339, doi. 10.1016/j.jalz.2018.06.164
- By:
- Publication type:
- Article
Trafficking regulator of GLUT4-1 (TRARG1) is a GSK3 substrate.
- Published in:
- Biochemical Journal, 2022, v. 479, n. 11, p. 1237, doi. 10.1042/BCJ20220153
- By:
- Publication type:
- Article
Author Correction: Limited oxygen in standard cell culture alters metabolism and function of differentiated cells.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Limited oxygen in standard cell culture alters metabolism and function of differentiated cells.
- Published in:
- EMBO Journal, 2024, v. 43, n. 11, p. 2127, doi. 10.1038/s44318-024-00084-7
- By:
- Publication type:
- Article
A high-content endogenous GLUT4 trafficking assay reveals new aspects of adipocyte biology.
- Published in:
- Life Science Alliance, 2023, v. 6, n. 1, p. 1, doi. 10.26508/lsa.202201585
- By:
- Publication type:
- Article
Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.
- Published in:
- Acta Neuropathologica, 2019, v. 138, n. 2, p. 237, doi. 10.1007/s00401-019-02026-8
- By:
- Publication type:
- Article
ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans.
- Published in:
- Molecular Neurodegeneration, 2018, v. 13, n. 1, p. N.PAG, doi. 10.1186/s13024-018-0289-x
- By:
- Publication type:
- Article